Phenibut – the Russian anti-anxiety drug linked to Gold Coast teens’ overdoses

Dr Janet Cheung

writer

Dr Janet Cheung

Lecturer in Pharmacy, University of Sydney

Dr Jonathan Penm

writer

Dr Jonathan Penm

Lecturer (Pharmacy), University of Sydney

Phenibut was initially developed in the 1960s in Russia as an anti-anxiety (anxiolytic) drug with cognitive enhancing properties. It has since attracted a strong following of users in the “smart drug” market, with claims of boosting memory recall and exam performance.

Originally given to Soviet cosmonauts to combat anxiety and insomnia, the powdered drug is suspected to have played a role in the recent overdose of seven teenagers at a Queensland private school.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Emily Nash

Dr Emily Nash

Abnormal Liver Function Test

Prof Richard Harvey

Prof Richard Harvey

Recurrent Nasal Polyps Management – When to Refer

Prof Kelly-Anne Phillips

Prof Kelly-Anne Phillips

Breast Density and Cancer Risk – What Every GP Can Put into Practice Tomorrow

A/Prof Adrian Mar

A/Prof Adrian Mar

Vitiligo – Early Detection and Early Treatment

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Dr Janet Cheung

writer

Dr Janet Cheung

Lecturer in Pharmacy, University of Sydney

Dr Jonathan Penm

writer

Dr Jonathan Penm

Lecturer (Pharmacy), University of Sydney

Test your knowledge

Recent articles

Latest GP poll

What is your view on changing the model of delivery for the doctors' health support service in your state or territory?

It should only change if there's clear evidence that a new model is better

0%

It should remain independent and locally governed

0%

It should be replaced with an untested national model

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

Recurrent Nasal Polyps Management – When to Refer

Tuesday 31st March, 7pm - 9pm AEDT

Speaker

Prof Richard Harvey

Rhinologist; Nose, Sinus, Allergy and Endoscopic Sinus and Skull Base Surgeon

Join Professor Richard Harvey for an overview of our current understanding of the pathophysiology of nasal polyps.